{{Rsnum
|rsid=2524276
|Chromosome=6
|position=31440488
|Orientation=minus
|GMAF=0.05326
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
|Gene=LINC01149
|Gene_s=LINC01149
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 85.7 | 13.4 | 0.9
| HCB | 99.3 | 0.7 | 0.0
| JPT | 100.0 | 0.0 | 0.0
| YRI | 82.3 | 17.7 | 0.0
| ASW | 86.0 | 12.3 | 1.8
| CHB | 99.3 | 0.7 | 0.0
| CHD | 97.2 | 2.8 | 0.0
| GIH | 90.1 | 9.9 | 0.0
| LWK | 93.6 | 6.4 | 0.0
| MEX | 91.4 | 6.9 | 1.7
| MKK | 76.9 | 21.2 | 1.9
| TSI | 88.2 | 9.8 | 2.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=22864933
  |Trait=Capecitabine sensitivity
  |Title=Identification of novel germline polymorphisms governing capecitabine sensitivity.
  |RiskAllele=
  |Pval=6E-6
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}